Schedule 13D ownership disclosure

CARA THERAPEUTICS INC

Security class unavailable · CUSIP: 140755109

Event date: 2015-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
32,437,091
Percent of class
20.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-15-000310
Form type
SC 13D
Filer
DEVON PARK BIOVENTURES LP
CIK
CIK 1356034
Filed
Mar 05, 2015
Reporting period
Feb 23, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub